Inogen, Inc.
Financials
Valuation Metrics
Inogen, Inc.'s Market Cap is $136M. At end of 2025 it was $183M. Ranked #3061 of 3,121 in US market (top 98%), #1414 of 1,463 on NASDAQ (top 97%), #196 of 205 in Health Care Equipment & Services (top 96%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $136M | US#3,061/3,121 Sec#196/205 |
| Revenue | $354M | US#2,390/3,121 Sec#150/205 |
| Net Income | $-25M | US—/3,121 Sec—/205 |
| Total Assets | $286M | US#2,923/3,121 Sec#178/205 |
| Net Assets | $175M | US#2,717/3,121 Sec#164/205 |
| Employees | 753 | US#2,107/3,121 Sec#149/205 |
| Value | ||
| P/B | 0.78x | US#206/3,121 Sec#13/205 |
| P/S | 0.38x | US#224/3,121 Sec#19/205 |
| FCF Yield | -7.12% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -14.07% | US#2,422/3,121 Sec#141/205 |
| ROA | -8.61% | US#2,634/3,121 Sec#154/205 |
| Op. Margin | -8.45% | US#2,532/3,121 Sec#153/205 |
| Revenue Growth | 3.15% | US#1,983/3,121 Sec#148/205 |
| Financial Health | ||
| Debt Ratio | 63.31% | US#700/3,121 Sec#77/205 |
| Total Debt | $16M | US#2,789/3,121 Sec#178/205 |
| FCF | $-10M | US#2,379/3,121 Sec#152/205 |
| Cash | $87M | US#2,305/3,121 Sec#145/205 |
| Current Ratio | 2.74x | US#884/3,121 Sec#88/205 |
| Performance | ||
| 1Y Return | -38.34% | US#2,769/3,121 Sec#178/205 |
| 1M Return | -8.39% | US#2,253/3,121 Sec#159/205 |
| From 52W High | -43.81% | US#2,566/3,121 Sec#171/205 |
| 1Y MDD | -42.68% | US#2,147/3,121 Sec#127/205 |
| Trading | ||
| Volume | 439,034 shares | US#2,122/3,121 Sec#150/205 |
| Trading Value | $2M | US#2,881/3,121 Sec#181/205 |
| Per Share | ||
| EPS | $-0.93 | US—/3,121 Sec—/205 |
| BPS | $6.59 | US#2,138/3,121 Sec#130/205 |
Company Info
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.